INR 712.55
(-2.66%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 696.99 Million INR | -0.8% |
2022 | 702.64 Million INR | -22.7% |
2021 | 909.03 Million INR | 57.96% |
2020 | 575.49 Million INR | 89.24% |
2019 | 304.11 Million INR | -5.8% |
2018 | 322.82 Million INR | 119.84% |
2017 | 146.84 Million INR | 215.1% |
2016 | 46.6 Million INR | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q2 | 271.99 Million INR | 28.29% |
2024 Q1 | 212.02 Million INR | -17.13% |
2023 Q3 | 202.4 Million INR | 64.23% |
2023 Q4 | 255.86 Million INR | 26.41% |
2023 Q1 | 156.3 Million INR | -21.41% |
2023 FY | 696.99 Million INR | -0.8% |
2023 Q2 | 123.24 Million INR | -21.15% |
2022 Q3 | 155.03 Million INR | -12.43% |
2022 Q1 | 154.24 Million INR | -12.27% |
2022 Q4 | 198.89 Million INR | 28.29% |
2022 Q2 | 177.04 Million INR | 14.78% |
2022 FY | 702.64 Million INR | -22.7% |
2021 Q4 | 175.81 Million INR | -9.25% |
2021 FY | 909.03 Million INR | 57.96% |
2021 Q3 | 193.73 Million INR | -10.33% |
2021 Q2 | 216.04 Million INR | -31.48% |
2021 Q1 | 315.3 Million INR | 32.6% |
2020 Q4 | 237.78 Million INR | 0.0% |
2020 FY | 575.49 Million INR | 89.24% |
2019 FY | 304.11 Million INR | -5.8% |
2019 Q4 | 91.57 Million INR | 0.0% |
2018 FY | 322.82 Million INR | 119.84% |
2017 FY | 146.84 Million INR | 215.1% |
2016 FY | 46.6 Million INR | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Dr. Lal PathLabs Limited | 4.76 Billion INR | 85.366% |
Metropolis Healthcare Limited | 2.05 Billion INR | 66.089% |
Thyrocare Technologies Limited | 917 Million INR | 23.992% |
Vijaya Diagnostic Centre Limited | 3.62 Billion INR | 80.791% |
Vimta Labs Limited | 536.04 Million INR | -30.023% |